{"id":3991,"date":"2016-09-19T15:19:07","date_gmt":"2016-09-19T15:19:07","guid":{"rendered":"https:\/\/laforcedmd.com\/?p=3991"},"modified":"2022-05-03T18:25:42","modified_gmt":"2022-05-03T18:25:42","slug":"eteplirsen-unprecedented-decision-fda","status":"publish","type":"post","link":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/","title":{"rendered":"An unprecedented decision by the FDA"},"content":{"rendered":"<h3><strong>The FDA has just announced an unprecedented decision\u2026<\/strong><\/h3>\n<h3>The children with Duchenne muscular dystrophy were heard because it\u2019s \u201cyes\u201d to Eteplirsen!<\/h3>\n<p>Eteplirsen was approved! This is absolutely fantastic news, but more importantly, it is a path opening up for other treatments being developed in the fight against Duchenne muscular dystrophy (DMD). Note however that this drug is not a cure and that it only works on the 13% of DMD patients who have the specific mutation.<\/p>\n<p><em>\u201cThe U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys 51 is specifically indicated for patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skipping, which affects about 13 percent of the population with DMD.\u201d<\/em> (<a href=\"http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/UCM521263\">FDA Press Release<\/a>)<\/p>\n<h3>About eteplirsen<\/h3>\n<p>This treatment uses a specific exon-skipping technique to jump over a portion of genetic machinery that produces a non-working, mutated form of dystrophin in children with DMD. Its aim is to restore the machinery\u2019s ability to read genetic code, so it can produce a less mutated form of dystrophin that works in children with DMD.<\/p>\n<p>The production of a partly functional dystrophin may delay muscle destruction and extend mobility in children with this devastating, rare disease. More specifically, eteplirsen triggers the skipping of exon 51, which occurs in 13% of children with DMD.<\/p>\n<h3>About Duchenne muscular dystrophy (DMD)<\/h3>\n<p>Duchenne muscular dystrophy (DMD) \u2013 A degenerative disease of the muscles for which there is no treatment<br \/>\nDuchenne muscular dystrophy (DMD) is a disease that almost exclusively affects boys and whose incidence is 1 in 3,500. It is extremely rare that Duchenne muscular dystrophy (DMD) will affect girls. Those affected are usually diagnosed around the age of five, but symptoms may be visible from early childhood. It is a degenerative disease of the muscles caused by a genetic mutation. The Duchenne muscular dystrophy (DMD) \u2013 for which no treatment is currently available \u2013 directly affects skeletal muscles. Without treatment, the consequences of the disease are dire for those afflicted and their families.<\/p>\n<h3><strong>Parents and children across Canada: Join the Force\u2026<\/strong><\/h3>\n<p>Our goal is to make Eteplirsen available in Canada as soon as possible!<\/p>\n<p>To subscribe to our newsletter, please <a href=\"\/?page_id=3379\"><u>step this way<\/u><\/a>.<\/p>\n<p>You can also read these interesting article<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/pharmalot\/2016\/09\/19\/sarepta-wins-dmd-drug-approval\/\">Stat<\/a><\/p>\n<p class=\"p1\"><a href=\"https:\/\/sarepta.com\/\"><span class=\"s4\">Sarepta Therapeutics<\/span><\/a><\/p>\n<p class=\"p4\"><a href=\"http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/UCM521263\">FDA<\/a><\/p>\n<p class=\"p4\"><a href=\"https:\/\/www.thestreet.com\/story\/13673965\/1\/sarepta-secures-fda-approval-for-duchenne-drug-after-long-fight.html\">The Street<\/a><\/p>\n<p class=\"p4\">Our blog post La Force \u00a0(avril 2016) <a href=\"\/?p=3292\">Part 1<\/a>\u00a0 <a href=\"\/?p=3295\">Part 2<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The FDA has just announced an unprecedented decision\u2026 The children with Duchenne muscular dystrophy were heard because it\u2019s \u201cyes\u201d to Eteplirsen! Eteplirsen was approved! This is absolutely fantastic news, but more importantly, it is a path opening up for other treatments being developed in the fight against Duchenne muscular dystrophy (DMD). Note however that this [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":4789,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[],"class_list":["post-3991","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eteplirsen is approved by an unprecdented decision by the FDA<\/title>\n<meta name=\"description\" content=\"Eteplirsen is approved! The children with Duchenne muscular dystrophy were heard. This decision by the FDA is unprecdented the voice of patients were heard.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eteplirsen is approved by an unprecdented decision by the FDA\" \/>\n<meta property=\"og:description\" content=\"Eteplirsen is approved! The children with Duchenne muscular dystrophy were heard. This decision by the FDA is unprecdented the voice of patients were heard.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"La Force dmd\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-19T15:19:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-03T18:25:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/laforcedmd.com\/wp-content\/uploads\/2017\/04\/eteplirsen-unprecedented-decision-fda.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"815\" \/>\n\t<meta property=\"og:image:height\" content=\"356\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marie\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marie\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/\"},\"author\":{\"name\":\"Marie\",\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/#\\\/schema\\\/person\\\/aa9947f206c7912f07291299569bf4bf\"},\"headline\":\"An unprecedented decision by the FDA\",\"datePublished\":\"2016-09-19T15:19:07+00:00\",\"dateModified\":\"2022-05-03T18:25:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/\"},\"wordCount\":394,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/laforcedmd.com\\\/wp-content\\\/uploads\\\/2017\\\/04\\\/eteplirsen-unprecedented-decision-fda.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/\",\"url\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/\",\"name\":\"Eteplirsen is approved by an unprecdented decision by the FDA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/laforcedmd.com\\\/wp-content\\\/uploads\\\/2017\\\/04\\\/eteplirsen-unprecedented-decision-fda.jpg\",\"datePublished\":\"2016-09-19T15:19:07+00:00\",\"dateModified\":\"2022-05-03T18:25:42+00:00\",\"description\":\"Eteplirsen is approved! The children with Duchenne muscular dystrophy were heard. This decision by the FDA is unprecdented the voice of patients were heard.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/#primaryimage\",\"url\":\"https:\\\/\\\/laforcedmd.com\\\/wp-content\\\/uploads\\\/2017\\\/04\\\/eteplirsen-unprecedented-decision-fda.jpg\",\"contentUrl\":\"https:\\\/\\\/laforcedmd.com\\\/wp-content\\\/uploads\\\/2017\\\/04\\\/eteplirsen-unprecedented-decision-fda.jpg\",\"width\":815,\"height\":356},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/eteplirsen-unprecedented-decision-fda\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"An unprecedented decision by the FDA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/#website\",\"url\":\"https:\\\/\\\/laforcedmd.com\\\/\",\"name\":\"La Force dmd\",\"description\":\"Dystrophie musculaire de Duchenne\",\"publisher\":{\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/laforcedmd.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/#organization\",\"name\":\"La Force dmd\",\"url\":\"https:\\\/\\\/laforcedmd.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/laforcedmd.com\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/logo-la-force-dmd.jpg\",\"contentUrl\":\"https:\\\/\\\/laforcedmd.com\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/logo-la-force-dmd.jpg\",\"width\":500,\"height\":125,\"caption\":\"La Force dmd\"},\"image\":{\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/laforcedmd.com\\\/#\\\/schema\\\/person\\\/aa9947f206c7912f07291299569bf4bf\",\"name\":\"Marie\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1a48fc20a72f762931838bcbd4de5af98782583e41b71b0b89e27d77b1de81e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1a48fc20a72f762931838bcbd4de5af98782583e41b71b0b89e27d77b1de81e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1a48fc20a72f762931838bcbd4de5af98782583e41b71b0b89e27d77b1de81e?s=96&d=mm&r=g\",\"caption\":\"Marie\"},\"url\":\"https:\\\/\\\/laforcedmd.com\\\/en\\\/author\\\/marie\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eteplirsen is approved by an unprecdented decision by the FDA","description":"Eteplirsen is approved! The children with Duchenne muscular dystrophy were heard. This decision by the FDA is unprecdented the voice of patients were heard.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/","og_locale":"en_US","og_type":"article","og_title":"Eteplirsen is approved by an unprecdented decision by the FDA","og_description":"Eteplirsen is approved! The children with Duchenne muscular dystrophy were heard. This decision by the FDA is unprecdented the voice of patients were heard.","og_url":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/","og_site_name":"La Force dmd","article_published_time":"2016-09-19T15:19:07+00:00","article_modified_time":"2022-05-03T18:25:42+00:00","og_image":[{"width":815,"height":356,"url":"https:\/\/laforcedmd.com\/wp-content\/uploads\/2017\/04\/eteplirsen-unprecedented-decision-fda.jpg","type":"image\/jpeg"}],"author":"Marie","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marie","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/#article","isPartOf":{"@id":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/"},"author":{"name":"Marie","@id":"https:\/\/laforcedmd.com\/#\/schema\/person\/aa9947f206c7912f07291299569bf4bf"},"headline":"An unprecedented decision by the FDA","datePublished":"2016-09-19T15:19:07+00:00","dateModified":"2022-05-03T18:25:42+00:00","mainEntityOfPage":{"@id":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/"},"wordCount":394,"commentCount":0,"publisher":{"@id":"https:\/\/laforcedmd.com\/#organization"},"image":{"@id":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/laforcedmd.com\/wp-content\/uploads\/2017\/04\/eteplirsen-unprecedented-decision-fda.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/","url":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/","name":"Eteplirsen is approved by an unprecdented decision by the FDA","isPartOf":{"@id":"https:\/\/laforcedmd.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/#primaryimage"},"image":{"@id":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/laforcedmd.com\/wp-content\/uploads\/2017\/04\/eteplirsen-unprecedented-decision-fda.jpg","datePublished":"2016-09-19T15:19:07+00:00","dateModified":"2022-05-03T18:25:42+00:00","description":"Eteplirsen is approved! The children with Duchenne muscular dystrophy were heard. This decision by the FDA is unprecdented the voice of patients were heard.","breadcrumb":{"@id":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/#primaryimage","url":"https:\/\/laforcedmd.com\/wp-content\/uploads\/2017\/04\/eteplirsen-unprecedented-decision-fda.jpg","contentUrl":"https:\/\/laforcedmd.com\/wp-content\/uploads\/2017\/04\/eteplirsen-unprecedented-decision-fda.jpg","width":815,"height":356},{"@type":"BreadcrumbList","@id":"https:\/\/laforcedmd.com\/en\/eteplirsen-unprecedented-decision-fda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/laforcedmd.com\/en\/"},{"@type":"ListItem","position":2,"name":"An unprecedented decision by the FDA"}]},{"@type":"WebSite","@id":"https:\/\/laforcedmd.com\/#website","url":"https:\/\/laforcedmd.com\/","name":"La Force dmd","description":"Dystrophie musculaire de Duchenne","publisher":{"@id":"https:\/\/laforcedmd.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/laforcedmd.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/laforcedmd.com\/#organization","name":"La Force dmd","url":"https:\/\/laforcedmd.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/laforcedmd.com\/#\/schema\/logo\/image\/","url":"https:\/\/laforcedmd.com\/wp-content\/uploads\/2022\/06\/logo-la-force-dmd.jpg","contentUrl":"https:\/\/laforcedmd.com\/wp-content\/uploads\/2022\/06\/logo-la-force-dmd.jpg","width":500,"height":125,"caption":"La Force dmd"},"image":{"@id":"https:\/\/laforcedmd.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/laforcedmd.com\/#\/schema\/person\/aa9947f206c7912f07291299569bf4bf","name":"Marie","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f1a48fc20a72f762931838bcbd4de5af98782583e41b71b0b89e27d77b1de81e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f1a48fc20a72f762931838bcbd4de5af98782583e41b71b0b89e27d77b1de81e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f1a48fc20a72f762931838bcbd4de5af98782583e41b71b0b89e27d77b1de81e?s=96&d=mm&r=g","caption":"Marie"},"url":"https:\/\/laforcedmd.com\/en\/author\/marie\/"}]}},"_links":{"self":[{"href":"https:\/\/laforcedmd.com\/en\/wp-json\/wp\/v2\/posts\/3991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/laforcedmd.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/laforcedmd.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/laforcedmd.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/laforcedmd.com\/en\/wp-json\/wp\/v2\/comments?post=3991"}],"version-history":[{"count":1,"href":"https:\/\/laforcedmd.com\/en\/wp-json\/wp\/v2\/posts\/3991\/revisions"}],"predecessor-version":[{"id":11224,"href":"https:\/\/laforcedmd.com\/en\/wp-json\/wp\/v2\/posts\/3991\/revisions\/11224"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/laforcedmd.com\/en\/wp-json\/wp\/v2\/media\/4789"}],"wp:attachment":[{"href":"https:\/\/laforcedmd.com\/en\/wp-json\/wp\/v2\/media?parent=3991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/laforcedmd.com\/en\/wp-json\/wp\/v2\/categories?post=3991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/laforcedmd.com\/en\/wp-json\/wp\/v2\/tags?post=3991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}